7Baggers
 Alterity Therapeutics Discloses Equity Derivative Positions  TipRanks Thu, 13 Nov 2025 04:52:48 GMT
 Alterity shows promise in MSA therapy  The Australian Wed, 12 Nov 2025 00:02:00 GMT
 Alterity Therapeutics Presents Promising Impact of ATH434  GlobeNewswire Mon, 10 Nov 2025 12:25:00 GMT
 how pharvaris n.v. stock performs during market volatility  Fundação Cultural do Pará Thu, 06 Nov 2025 06:25:48 GMT
 published on: 2025-11-02 23:25:10  newser.com Mon, 03 Nov 2025 05:25:54 GMT
 published on: 2025-11-01 12:04:02  newser.com Sat, 01 Nov 2025 17:04:02 GMT
 most active stocks: us stocks with the highest trading volume today  Yahoo! Finance Australia Sat, 01 Nov 2025 08:36:16 GMT
 published on: 2025-11-01 00:13:08  newser.com Sat, 01 Nov 2025 05:13:08 GMT
 Alterity Therapeutics: Appendix 4C - Q1 FY26 Quarterly Cash Flow Report  The Manila Times Fri, 31 Oct 2025 07:00:00 GMT
 ath434 shows promise as breakthrough msa treatment  GuruFocus Fri, 31 Oct 2025 07:00:00 GMT
 alterity therapeutics announces 2025 annual general meeting  TipRanks Tue, 21 Oct 2025 04:20:38 GMT
 Alterity Therapeutics Announces 2025 Annual General Meeting  TipRanks Mon, 20 Oct 2025 07:00:00 GMT
 alterity therapeutics raises a$40 million  MSN Sun, 19 Oct 2025 12:29:11 GMT
 Alterity Therapeutics Limited's (ASX:ATH) Path To Profitability  Yahoo Finance Sat, 11 Oct 2025 07:00:00 GMT
 Alterity presents positive phase II ATH434 data  The Australian Fri, 10 Oct 2025 07:00:00 GMT
 alterity presents positive phase ii ath434 data  The Australian Thu, 09 Oct 2025 22:14:00 GMT
 alterity therapeutics presents data from ath434 phase 2 trial  TipRanks Thu, 09 Oct 2025 12:01:59 GMT
 alterity therapeutics (athe) unveils promising phase 2 results f  GuruFocus Thu, 09 Oct 2025 07:00:00 GMT
 Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434  Yahoo Finance Tue, 30 Sep 2025 07:00:00 GMT
 StockTake: Alterity Therapeutics  The Australian Tue, 30 Sep 2025 07:00:00 GMT
 alterity therapeutics sets agm and director nomination dates  TipRanks Tue, 23 Sep 2025 07:00:00 GMT
 alterity therapeutics announces director’s interest change  The Globe and Mail Thu, 18 Sep 2025 07:00:00 GMT
 alterity therapeutics announces securities notice  MSN Wed, 17 Sep 2025 13:16:03 GMT
 6-k: report of foreign private issuer [rules 13a-16 and 15d-16]  富途牛牛 Wed, 17 Sep 2025 07:00:00 GMT
 alterity therapeutics announces cessation of 35 million securities  The Globe and Mail Wed, 17 Sep 2025 07:00:00 GMT
 alterity therapeutics announces director’s interest change  TipRanks Wed, 17 Sep 2025 06:06:02 GMT
 Alterity Therapeutics Announces Director’s Interest Change  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 most active stocks: us stocks with the highest trading volume today  au.finance.yahoo.com Tue, 16 Sep 2025 04:58:47 GMT

Alterity Therapeutics Limited
(NASDAQ:ATHE) 

ATHE stock logo

Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinsonian's disease and other neurodegenerative diseases in Australia. The company's lead drug candidates is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It i...

Founded: 1997
CEO: David Stamler  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends